Knockdown of lncRNA ACTA2-AS1 reverses cisplatin resistance of ovarian cancer cells via inhibition of miR-378a-3p-regulated Wnt5a

LncRNA CRNDE attenuates chemoresistance in gastric cancer via SRSF6-regulated alternative splicing of PICALM

(2021) Feifei Zhang et al.   Molecular Cancer

LncRNA WDFY3-AS2 promotes cisplatin resistance and the cancer stem cell in ovarian cancer by regulating hsa-miR-139-5p/SDC4 axis

(2021) Yue Wu et al.   Cancer Cell International

Cancer statistics, 2020

(2020) Rebecca L. Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

LncRNA PTENP1 inhibits cervical cancer progression by suppressing miR-106b

(2020) Yingrui Fan et al.   Artificial Cells Nanomedicine and Biotechnology

A novel mechanism by which ACTA2-AS1 promotes cervical cancer progression: acting as a ceRNA of miR-143-3p to regulate SMAD3 expression

(2020) Lingli Luo et al.   Cancer Cell International

LncRNA PVT1 promotes gemcitabine resistance of pancreatic cancer via activating Wnt/β-catenin and autophagy pathway through modulating the miR-619-5p/Pygo2 and miR-619-5p/ATG14 axes

(2020) Cefan Zhou et al.   Molecular Cancer

NEAT1 Knockdown Suppresses the Cisplatin Resistance in Ovarian Cancer by Regulating miR-770-5p/PARP1 Axis

(2020) Mingzhe Zhu et al.   Cancer Management and Research

LncRNA SLC26A4-AS1 suppresses the MRN complex-mediated DNA repair signaling and thyroid cancer metastasis by destabilizing DDX5

(2020) Jupeng Yuan et al.   ONCOGENE

LncRNA MALAT1 Regulates the Progression and Cisplatin Resistance of Ovarian Cancer Cells via Modulating miR-1271-5p/E2F5 Axis

(2020) Yuqin Wang et al.   Cancer Management and Research

Gene regulation by long non-coding RNAs and its biological functions

(2020) Luisa Statello et al.   NATURE REVIEWS MOLECULAR CELL BIOLOGY

LncRNA ATXN8OS enhances tamoxifen resistance in breast cancer

(2020) Hongkai Zhang et al.   Open Medicine

lncRNA-PRLB Confers Paclitaxel Resistance of Ovarian Cancer Cells by Regulating RSF1/NF-κB Signaling Pathway

(2020) Yuzi Zhao et al.   CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS

MiR-1180 from bone marrow-derived mesenchymal stem cells induces glycolysis and chemoresistance in ovarian cancer cells by upregulating the Wnt signaling pathway

(2019) Zhuo-Wei Gu et al.   Journal of Zhejiang University-SCIENCE B

Mechanisms of lncRNA/microRNA interactions in angiogenesis

(2019) Zhuo Zhao et al.   LIFE SCIENCES

Weekly dose-dense chemotherapy in first-line epithelial ovarian, fallopian tube, or primary peritoneal carcinoma treatment (ICON8): primary progression free survival analysis results from a GCIG phase 3 randomised controlled trial

(2019) Andrew R Clamp et al.   LANCET

miR-378a-3p sensitizes ovarian cancer cells to cisplatin through targeting MAPK1/GRB2

(2018) Zhi-hong Xu et al.   BIOMEDICINE & PHARMACOTHERAPY

Wnt5a Increases Properties of Lung Cancer Stem Cells and Resistance to Cisplatin through Activation of Wnt5a/PKC Signaling Pathway

(2016) Jiali Yang et al.   Stem Cells International

miR-378a-3p modulates tamoxifen sensitivity in breast cancer MCF-7 cells through targeting GOLT1A

(2015) Kazuhiro Ikeda et al.   Scientific Reports

Function of lncRNAs and approaches to lncRNA-protein interactions

(2013) JuanJuan Zhu et al.   Science China-Life Sciences

Large intergenic non-coding RNA-RoR modulates reprogramming of human induced pluripotent stem cells

(2010) Sabine Loewer et al.   NATURE GENETICS

Long noncoding RNAs: functional surprises from the RNA world

(2009) J. E. Wilusz et al.   GENES & DEVELOPMENT

Long intronic noncoding RNA transcription: Expression noise or expression choice?

(2008) Rodrigo Louro et al.   GENOMICS